Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aytu BioScience, Inc.

2.18
-0.1100-4.80%
Post-market: 2.180.00000.00%17:24 EDT
Volume:97.00K
Turnover:214.94K
Market Cap:19.57M
PE:-2.62
High:2.36
Open:2.27
Low:2.17
Close:2.29
Loading ...
Jul 10, 2023

Major Issues Report

Form 8-K - Current report
Jun 24, 2023

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Jun 17, 2023

Beneficial Ownership Change

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
Jun 16, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Jun 12, 2023

Major Issues Report

Form 8-K - Current report
Jun 09, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jun 07, 2023

[Supp]Public Prospectus

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses
Jun 07, 2023

Correspondence

Form CORRESP - Correspondence
Jun 07, 2023

Correspondence

Form CORRESP - Correspondence
Jun 06, 2023

[Amend]Public Prospectus

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
May 27, 2023

Beneficial Ownership Change

Form SC 13D - General statement of acquisition of beneficial ownership
May 22, 2023

Major Issues Report

Form 8-K - Current report
May 11, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 11, 2023

Major Issues Report

8-K - Current report
May 01, 2023

Public Prospectus

S-1 - General form for registration of securities under the Securities Act of 1933
May 01, 2023

Major Issues Report

8-K - Current report
Apr 27, 2023

Major Issues Report

8-K - Current report
Apr 19, 2023

Major Issues Report

8-K - Current report
Mar 27, 2023

Major Issues Report

8-K - Current report
Feb 21, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]